CTP-543 PK with Itraconazole in Healthy Adults

Phase 1, open-label, single-arm trial of deuruxolitinib in alopecia areata, sponsored by Concert Pharmaceuticals. Primary endpoints: Area Under the Plasma Concentration-Time Curve from Time Zero to Time t at 48 hours, Area Under the Plasma Concentration-Time Curve from Time Zero to Infinity at 48 hours and 2 more. Started Mar 2021; status: completed.